Tréguer Frédéric
Clinique Saint-Joseph, Trélazé, France.
Rev Prat. 2020 Oct;70(8):915-920.
Cardiac rhythm management of patients with atrial fibrillation. Cardiac rhythm management of atrial fibrillation (AF) is essential to improve symptoms as well as outcomes in patients with AF; this can be achieved either by rhythm or rate control strategies. Many studies published between 2000 and 2010 have supported the point that these two strategies were both acceptable therapeutic options (without clear superiority of one to the other), even in heart failure patients, pinpointing the side effects and the lack of efficacy of many antiarrhythmic pharmacological drugs. Nevertheless, many patients remain symptomatic despite adequate ventricular rate control and eventually require sinus rhythm restoration and maintenance. Then, rhythm control options have evolved and now include catheter ablation either by radiofrequency or cryotherapy, which allow maintaining sinus rhythm and reduce AF-associated symptoms more reliably than antiarrhythmic drugs, particularly in younger patients. Furthermore, interest in rhythm control by catheter ablation has been reinvigorated by the results of recently published trials, especially in patients with heart failure. However, the impact of catheter ablation on morbidity and mortality have still to be proven before considering it in asymptomatic patients.
心房颤动患者的心律管理。心房颤动(AF)的心律管理对于改善AF患者的症状及预后至关重要;这可以通过节律控制或心率控制策略来实现。2000年至2010年间发表的许多研究都支持了这一观点,即这两种策略都是可接受的治疗选择(两者之间没有明显的优劣之分),即使在心力衰竭患者中也是如此,同时也指出了许多抗心律失常药物的副作用和疗效不佳。然而,尽管心室率得到了充分控制,许多患者仍有症状,最终需要恢复并维持窦性心律。于是,节律控制的选择不断发展,现在包括通过射频或冷冻疗法进行导管消融,与抗心律失常药物相比,导管消融能更可靠地维持窦性心律并减轻与AF相关的症状,尤其是在年轻患者中。此外,最近发表的试验结果重新激发了人们对导管消融进行节律控制的兴趣,特别是在心力衰竭患者中。然而,在考虑将导管消融用于无症状患者之前,其对发病率和死亡率的影响仍有待证实。